LivaNova PLC (LIVN)
USD 37.48
(-5.11%)
USD 37.48
(-5.11%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -68.49 Million USD | 87.77% |
| 2022 | 52.7 Million USD | 5955.56% |
| 2021 | -900 Thousand USD | 97.9% |
| 2020 | -42.8 Million USD | -189.17% |
| 2019 | 48 Million USD | 119.35% |
| 2018 | -248.1 Million USD | -359.25% |
| 2017 | 95.7 Million USD | 446.74% |
| 2016 | -27.6 Million USD | -131.13% |
| 2015 | 88.65 Million USD | 10.8% |
| 2014 | 80.01 Million USD | 2.13% |
| 2013 | 78.34 Million USD | 28.56% |
| 2012 | 60.94 Million USD | 23.9% |
| 2011 | 49.18 Million USD | 33.44% |
| 2010 | 36.86 Million USD | 94.12% |
| 2009 | 18.98 Million USD | 330.77% |
| 2008 | -8.22 Million USD | 83.39% |
| 2007 | -49.52 Million USD | 16.39% |
| 2006 | -59.23 Million USD | -358.98% |
| 2005 | -12.9 Million USD | -292.76% |
| 2004 | 6.69 Million USD | 42.95% |
| 2003 | 4.68 Million USD | 117.21% |
| 2002 | -27.21 Million USD | 0.0% |
| 2000 | -5.25 Million USD | 62.76% |
| 1999 | -14.1 Million USD | 12.96% |
| 1998 | -16.2 Million USD | -42.11% |
| 1997 | -11.4 Million USD | -9.62% |
| 1996 | -10.4 Million USD | -31.65% |
| 1995 | -7.9 Million USD | -21.54% |
| 1994 | -6.5 Million USD | -18.18% |
| 1993 | -5.5 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 38.86 Million USD | 144.16% |
| 2024 Q2 | 46.51 Million USD | 19.68% |
| 2024 Q3 | 35.61 Million USD | -23.42% |
| 2023 Q2 | 17.4 Million USD | 856.52% |
| 2023 Q3 | 4.5 Million USD | -74.14% |
| 2023 FY | 98.95 Million USD | 87.77% |
| 2023 Q4 | -88 Million USD | -2055.56% |
| 2023 Q1 | -2.3 Million USD | -116.43% |
| 2022 FY | 52.7 Million USD | 5955.56% |
| 2022 Q4 | 14 Million USD | 662.47% |
| 2022 Q3 | -2.48 Million USD | -114.11% |
| 2022 Q2 | 17.64 Million USD | 85.63% |
| 2022 Q1 | 9.5 Million USD | -61.67% |
| 2021 Q1 | -4.42 Million USD | 98.21% |
| 2021 Q2 | -34.86 Million USD | -688.18% |
| 2021 Q3 | 17.86 Million USD | 151.25% |
| 2021 Q4 | 24.8 Million USD | 38.8% |
| 2021 FY | -900 Thousand USD | 97.9% |
| 2020 Q3 | -7.5 Million USD | 32.55% |
| 2020 FY | -42.8 Million USD | -189.17% |
| 2020 Q2 | -11.13 Million USD | -291.6% |
| 2020 Q1 | 5.81 Million USD | 104.04% |
| 2020 Q4 | -247.7 Million USD | -3199.15% |
| 2019 Q1 | -20.77 Million USD | 92.48% |
| 2019 Q2 | -29.87 Million USD | -43.78% |
| 2019 Q4 | -143.97 Million USD | -658.89% |
| 2019 Q3 | 25.76 Million USD | 186.23% |
| 2019 FY | 48 Million USD | 119.35% |
| 2018 Q1 | 12.5 Million USD | -31.69% |
| 2018 Q3 | -5.75 Million USD | -126.65% |
| 2018 Q4 | -276.5 Million USD | -4702.85% |
| 2018 Q2 | 21.6 Million USD | 72.8% |
| 2018 FY | -248.1 Million USD | -359.25% |
| 2017 Q4 | 18.3 Million USD | -42.93% |
| 2017 FY | 95.7 Million USD | 446.74% |
| 2017 Q3 | 32.06 Million USD | 3.17% |
| 2017 Q2 | 31.07 Million USD | 266.97% |
| 2017 Q1 | -18.61 Million USD | 49.0% |
| 2016 Q4 | -36.5 Million USD | -258.8% |
| 2016 Q3 | 22.98 Million USD | 4.48% |
| 2016 FY | -27.6 Million USD | -131.13% |
| 2016 Q2 | 22 Million USD | 160.94% |
| 2016 Q1 | -36.1 Million USD | 0.0% |
| 2015 Q3 | -26.35 Million USD | -223.94% |
| 2015 FY | 88.65 Million USD | 10.8% |
| 2015 Q2 | 21.26 Million USD | 27.16% |
| 2015 Q1 | 16.72 Million USD | -29.35% |
| 2014 Q1 | 23.41 Million USD | 10.98% |
| 2014 Q2 | 22 Million USD | -6.04% |
| 2014 Q4 | 23.66 Million USD | -9.88% |
| 2014 Q3 | 26.26 Million USD | 19.35% |
| 2014 FY | 80.01 Million USD | 2.13% |
| 2013 Q3 | 21.88 Million USD | 60.89% |
| 2013 Q4 | 21.1 Million USD | -3.59% |
| 2013 Q1 | 20.46 Million USD | 0.11% |
| 2013 FY | 78.34 Million USD | 28.56% |
| 2013 Q2 | 13.6 Million USD | -33.52% |
| 2012 Q3 | 20.17 Million USD | 16.83% |
| 2012 Q1 | 17.96 Million USD | 9.57% |
| 2012 FY | 60.94 Million USD | 23.9% |
| 2012 Q4 | 20.44 Million USD | 1.33% |
| 2012 Q2 | 17.26 Million USD | -3.9% |
| 2011 Q3 | 15.06 Million USD | 30.9% |
| 2011 FY | 49.18 Million USD | 33.44% |
| 2011 Q4 | 16.39 Million USD | 8.84% |
| 2011 Q2 | 11.51 Million USD | -11.67% |
| 2011 Q1 | 13.03 Million USD | 11.36% |
| 2010 Q2 | 11.69 Million USD | -4.45% |
| 2010 Q1 | 12.23 Million USD | 35.49% |
| 2010 FY | 36.86 Million USD | 94.12% |
| 2010 Q3 | 12.76 Million USD | 9.18% |
| 2010 Q4 | 11.7 Million USD | -8.33% |
| 2009 Q1 | 6.7 Million USD | 34.64% |
| 2009 Q4 | 9.03 Million USD | -0.58% |
| 2009 FY | 18.98 Million USD | 330.77% |
| 2009 Q3 | 9.08 Million USD | 39.48% |
| 2009 Q2 | 6.51 Million USD | -2.93% |
| 2008 FY | -8.22 Million USD | 83.39% |
| 2008 Q2 | 2.78 Million USD | -7.99% |
| 2008 Q4 | 4.98 Million USD | 10.32% |
| 2008 Q1 | 3.02 Million USD | 1040.79% |
| 2008 Q3 | 4.51 Million USD | 62.34% |
| 2007 Q2 | -7.9 Million USD | 22.46% |
| 2007 Q1 | -10.2 Million USD | 45.34% |
| 2007 Q3 | -3.6 Million USD | 54.38% |
| 2007 Q4 | 265.05 Thousand USD | 107.35% |
| 2007 FY | -49.52 Million USD | 16.39% |
| 2006 Q1 | -3.22 Million USD | 77.88% |
| 2006 Q4 | -18.66 Million USD | -52.25% |
| 2006 Q3 | -12.25 Million USD | -45.75% |
| 2006 FY | -59.23 Million USD | -358.98% |
| 2006 Q2 | -8.4 Million USD | -160.47% |
| 2005 FY | -12.9 Million USD | -292.76% |
| 2005 Q4 | -14.59 Million USD | 34.84% |
| 2005 Q3 | -22.39 Million USD | -17.81% |
| 2005 Q2 | -19.01 Million USD | -180.79% |
| 2005 Q1 | -6.77 Million USD | -551.01% |
| 2004 Q1 | -851.53 Thousand USD | -103.7% |
| 2004 Q2 | -2.99 Million USD | -252.06% |
| 2004 Q3 | -2.09 Million USD | 30.07% |
| 2004 FY | 6.69 Million USD | 42.95% |
| 2004 Q4 | -1.04 Million USD | 50.39% |
| 2003 Q2 | 2.62 Million USD | -35.39% |
| 2003 Q4 | 23.03 Million USD | 494.59% |
| 2003 FY | 4.68 Million USD | 117.21% |
| 2003 Q1 | 4.06 Million USD | 13.86% |
| 2003 Q3 | 3.87 Million USD | 47.44% |
| 2002 Q3 | 1.09 Million USD | 126.98% |
| 2002 Q4 | 3.57 Million USD | 227.24% |
| 2002 FY | -27.21 Million USD | 0.0% |
| 2002 Q2 | -4.04 Million USD | 42.51% |
| 2002 Q1 | -7.03 Million USD | -20.32% |
| 2001 Q3 | -7.15 Million USD | 0.18% |
| 2001 Q2 | -7.16 Million USD | -53.6% |
| 2001 Q4 | -5.84 Million USD | 18.26% |
| 2001 Q1 | -4.66 Million USD | -20.87% |
| 2000 Q2 | -2.47 Million USD | -661.45% |
| 2000 Q1 | -325.2 Thousand USD | 34.96% |
| 2000 FY | -5.25 Million USD | 62.76% |
| 2000 Q4 | -3.86 Million USD | -12.39% |
| 2000 Q3 | -3.43 Million USD | -38.75% |
| 1999 Q2 | -900 Thousand USD | 73.53% |
| 1999 Q1 | -3.4 Million USD | 22.73% |
| 1999 Q3 | -1.9 Million USD | -111.11% |
| 1999 Q4 | -500 Thousand USD | 73.68% |
| 1999 FY | -14.1 Million USD | 12.96% |
| 1998 FY | -16.2 Million USD | -42.11% |
| 1998 Q4 | -4.4 Million USD | 18.52% |
| 1998 Q3 | -5.4 Million USD | 5.26% |
| 1998 Q2 | -5.7 Million USD | -159.09% |
| 1998 Q1 | -2.2 Million USD | 29.03% |
| 1997 Q1 | -3 Million USD | -11.11% |
| 1997 FY | -11.4 Million USD | -9.62% |
| 1997 Q4 | -3.1 Million USD | 40.38% |
| 1997 Q3 | -5.2 Million USD | -48.57% |
| 1997 Q2 | -3.5 Million USD | -16.67% |
| 1996 Q1 | -2.5 Million USD | 3.85% |
| 1996 Q2 | -3.2 Million USD | -28.0% |
| 1996 Q3 | -1.9 Million USD | 40.63% |
| 1996 Q4 | -2.7 Million USD | -42.11% |
| 1996 FY | -10.4 Million USD | -31.65% |
| 1995 Q4 | -2.6 Million USD | -13.04% |
| 1995 Q1 | -1.8 Million USD | 0.0% |
| 1995 FY | -7.9 Million USD | -21.54% |
| 1995 Q3 | -2.3 Million USD | 11.54% |
| 1995 Q2 | -2.6 Million USD | -44.44% |
| 1994 Q4 | -1.8 Million USD | 0.0% |
| 1994 FY | -6.5 Million USD | -18.18% |
| 1994 Q1 | -1.5 Million USD | 16.67% |
| 1994 Q2 | -1.4 Million USD | 6.67% |
| 1994 Q3 | -1.8 Million USD | -28.57% |
| 1993 FY | -5.5 Million USD | 0.0% |
| 1993 Q1 | -1.1 Million USD | 0.0% |
| 1993 Q4 | -1.8 Million USD | -5.88% |
| 1993 Q2 | -1.7 Million USD | -54.55% |
| 1993 Q3 | -1.7 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -376.972% |
| Cerus Corporation | -30.05 Million USD | -127.924% |
| OrthoPediatrics Corp. | -25.76 Million USD | -165.846% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -544.909% |
| Talis Biomedical Corporation | -66.81 Million USD | -2.519% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -296.034% |
| Inogen, Inc. | -109.38 Million USD | 37.38% |
| Spectral AI, Inc. | -12.98 Million USD | -427.557% |
| Nano-X Imaging Ltd. | -62.58 Million USD | -9.441% |
| CVRx, Inc. | -43.1 Million USD | -58.917% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -1841.553% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -451.159% |
| Orthofix Medical Inc. | -139.11 Million USD | 50.76% |
| Venus Concept Inc. | -28.3 Million USD | -141.965% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | -26.782% |
| Bioventus Inc. | -81.72 Million USD | 16.185% |
| BrainsWay Ltd. | -4.92 Million USD | -1290.258% |
| Envoy Medical, Inc. | -18.37 Million USD | -272.859% |
| electroCore, Inc. | -18.8 Million USD | -264.254% |
| IceCure Medical Ltd | -15.57 Million USD | -339.766% |
| Lucid Diagnostics Inc. | -48.48 Million USD | -41.285% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -296.675% |
| MaxCyte, Inc. | -48.29 Million USD | -41.821% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -472.953% |
| Nexalin Technology, Inc. | -5.69 Million USD | -1102.501% |
| PAVmed Inc | -68.79 Million USD | 0.432% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | -21.1% |
| RxSight, Inc. | -50.08 Million USD | -36.764% |
| Sight Sciences, Inc. | -57.27 Million USD | -19.597% |
| SI-BONE, Inc. | -46.93 Million USD | -45.955% |
| TELA Bio, Inc. | -44.07 Million USD | -55.412% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | -26.497% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | -33.192% |
| 908 Devices Inc. | -42.75 Million USD | -60.199% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 60.496% |
| Nemaura Medical Inc. | -9.59 Million USD | -613.875% |
| NeuroPace, Inc. | -27.17 Million USD | -152.072% |
| LENSAR, Inc. | -12.22 Million USD | -460.128% |
| Apyx Medical Corporation | -17.25 Million USD | -296.883% |
| Cutera, Inc. | -156.23 Million USD | 56.156% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -696.118% |
| BioSig Technologies, Inc. | -28.51 Million USD | -140.243% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 21.841% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -205.168% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 161.419% |
| Axonics, Inc. | -26.05 Million USD | -162.878% |
| Outset Medical, Inc. | -169.77 Million USD | 59.652% |
| IRIDEX Corporation | -10 Million USD | -584.501% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 37.256% |
| IRadimed Corporation | 20.03 Million USD | 441.884% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -730.782% |
| INVO Bioscience, Inc. | -6.76 Million USD | -912.213% |
| Telesis Bio, Inc. | -35.15 Million USD | -94.873% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 578.004% |
| Varex Imaging Corporation | 32.1 Million USD | 313.389% |
| Quipt Home Medical Corp. | 3.91 Million USD | 1847.844% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -464.559% |
| Pulmonx Corporation | -61.93 Million USD | -10.597% |
| Dynatronics Corporation | -2.27 Million USD | -2913.487% |
| Modular Medical, Inc. | -17.52 Million USD | -290.77% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -367.914% |
| Semler Scientific, Inc. | 22.25 Million USD | 407.773% |
| InMode Ltd. | 195.66 Million USD | 135.009% |
| Bruker Corporation | 436.9 Million USD | 115.678% |
| Cytosorbents Corporation | -31.2 Million USD | -119.48% |
| DexCom, Inc. | 597.7 Million USD | 111.46% |
| Align Technology, Inc. | 643.33 Million USD | 110.647% |
| Viveve Medical, Inc. | -21.55 Million USD | -217.812% |
| ZimVie Inc. | -30.93 Million USD | -121.397% |
| Movano Inc. | -29.69 Million USD | -130.711% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -145.997% |
| Nexalin Technology, Inc. | -5.69 Million USD | -1102.501% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -1841.553% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 70.631% |
| Profound Medical Corp. | -28.61 Million USD | -139.37% |
| Insulet Corporation | 220 Million USD | 131.135% |
| enVVeno Medical Corporation | -25.23 Million USD | -171.408% |
| Surmodics, Inc. | -5.64 Million USD | -1113.428% |
| iCAD, Inc. | -7.68 Million USD | -790.857% |
| Nuwellis, Inc. | -17.63 Million USD | -288.531% |
| Biotricity, Inc. | -8.82 Million USD | -675.894% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 45.272% |
| Aethlon Medical, Inc. | -12.63 Million USD | -442.062% |
| InspireMD, Inc. | -21.14 Million USD | -223.975% |
| PAVmed Inc. | -68.79 Million USD | 0.432% |
| BIOLASE, Inc. | -17.93 Million USD | -281.881% |
| Beyond Air, Inc. | -63 Million USD | -8.717% |
| FONAR Corporation | 16.53 Million USD | 514.252% |
| AxoGen, Inc. | -21.46 Million USD | -219.159% |
| Vivani Medical, Inc. | -26.96 Million USD | -154.026% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 479.68% |
| Inari Medical, Inc. | -14.03 Million USD | -388.156% |
| UFP Technologies, Inc. | 57.66 Million USD | 218.788% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -1290.088% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -986.275% |
| Tenon Medical, Inc. | -15.72 Million USD | -335.544% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -816.484% |
| Co-Diagnostics, Inc. | -42.7 Million USD | -60.393% |
| AdaptHealth Corp. | -598.4 Million USD | 88.553% |
| Sintx Technologies, Inc. | -13.35 Million USD | -412.786% |
| NanoVibronix, Inc. | -3.43 Million USD | -1893.539% |
| Quanterix Corporation | -49.7 Million USD | -37.82% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -464.559% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -17831.414% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 79.52% |
| TransMedics Group, Inc. | -28.72 Million USD | -138.445% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -190.098% |
| NeuroMetrix, Inc. | -7.15 Million USD | -857.81% |
| Hyperfine, Inc. | -48.11 Million USD | -42.363% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | -5.339% |
| Biomerica, Inc. | -6.36 Million USD | -975.828% |
| Bone Biologics Corporation | -9.42 Million USD | -626.515% |
| AVITA Medical, Inc. | -40.4 Million USD | -69.541% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -564.306% |
| Silk Road Medical, Inc | -59.27 Million USD | -15.567% |